Working conditions are the larger problem. Burnout, chronic understaffing, and high turnover are among the most consistent ...
As I prepared for my appointment, the hospital asked me to sign its registration forms and to sign up for MyChart. In the ...
The XBI is still up 24%, although it’s down 11% from the August high. The retreat doesn’t look that alarming relative to the ...
Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...
U.S. health officials are moving ahead with a plan to allow specialty pharmacies to produce certain peptides, a class of ...
Day two of the STAT Summit is just kicking off as this newsletter lands in inboxes.
About 40% of high school students reported binge-eating in the past month in a new CDC survey, highlighting how widespread ...
Kenya reports a second Ebola case. Meanwhile, the situation in Congo is still quite dire. Authorities have confirmed more ...
The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is prepared ...
Three former FDA chiefs lit into the Trump administration, criticizing the now former FDA officials who oversaw a massive ...
Verastem Oncology reports encouraging early results for its KRAS G12D inhibitor, which it’s studying in more than 200 ...
A schoolteacher diagnosed with melanoma provides an inside look at what it was like to be treated with a cancer vaccine developed by Merck and Moderna.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results